Novavax, Inc. (NVAX) Reports In-Line Q1 EPS
Tweet
Share
E-mailGet Alerts NVAX Hot Sheet
Price: $9.06 +0.67%
EPS Growth %: -164.5%
Financial Fact:
Revenue: 102K
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: -164.5%
Financial Fact:
Revenue: 102K
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Novavax, Inc. (NASDAQ: NVAX) reported Q1 EPS of ($0.07), in-line with the analyst estimate of ($0.07). Revenue for the quarter came in at $7.5 million, versus $3.8 million reported last year.
For earnings history and earnings-related data on Novavax, Inc. (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
- Benchmark Reiterates Buy Rating on Cineverse (CNVS) Ahead of Q4 Results
- Benchmark Reiterates Hold Rating on Old Dominion Freight Line (ODFL) as 'Quality Largely Priced in'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
